Spencer Pharmaceutical Net Income
| SPPH Stock | USD 0.0001 0.00 0.00% |
In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Spencer Pharmaceutical, as well as the relationship between them.
Spencer Pharmaceutical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Spencer Pharmaceutical's valuation are provided below:We have found seventy-five available fundamental trend indicators for Spencer Pharmaceutical, which can be analyzed and compared to other ratios and to its competition. Traders should compare all of Spencer Pharmaceutical current fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The Spencer Pharmaceutical's current Enterprise Value is estimated to increase to about 125.9 K This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Loss | -848.9 K | -806.4 K | |
| Net Loss | -848.9 K | -806.4 K | |
| Net Loss | -848.9 K | -806.4 K | |
| Net Loss | (0.99) | (1.04) | |
| Net Income Per E B T | 1.14 | 1.10 |
Spencer | Net Income | Build AI portfolio with Spencer Stock |
The Net Income trend for Spencer Pharmaceutical offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Spencer Pharmaceutical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Spencer Pharmaceutical's Net Income Growth Pattern
Below is the plot of the Net Income of Spencer Pharmaceutical over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Spencer Pharmaceutical financial statement analysis. It represents the amount of money remaining after all of Spencer Pharmaceutical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Spencer Pharmaceutical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Spencer Pharmaceutical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (943.2 K) | 10 Years Trend |
|
Net Income |
| Timeline |
Spencer Net Income Regression Statistics
| Arithmetic Mean | (848,174) | |
| Geometric Mean | 888,162 | |
| Coefficient Of Variation | (39.44) | |
| Mean Deviation | 156,589 | |
| Median | (943,196) | |
| Standard Deviation | 334,511 | |
| Sample Variance | 111.9B | |
| Range | 1.4M | |
| R-Value | (0.34) | |
| Mean Square Error | 105.2B | |
| R-Squared | 0.12 | |
| Significance | 0.18 | |
| Slope | (22,843) | |
| Total Sum of Squares | 1.8T |
Spencer Net Income History
Other Fundumenentals of Spencer Pharmaceutical
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Spencer Pharmaceutical Net Income component correlations
Spencer Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Spencer Pharmaceutical is extremely important. It helps to project a fair market value of Spencer Stock properly, considering its historical fundamentals such as Net Income. Since Spencer Pharmaceutical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Spencer Pharmaceutical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Spencer Pharmaceutical's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Biotechnology market expansion? Will Spencer introduce new products? Factors like these will boost the valuation of Spencer Pharmaceutical. If investors know Spencer will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Spencer Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Spencer Pharmaceutical is measured differently than its book value, which is the value of Spencer that is recorded on the company's balance sheet. Investors also form their own opinion of Spencer Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Spencer Pharmaceutical's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Spencer Pharmaceutical's market value can be influenced by many factors that don't directly affect Spencer Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spencer Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Spencer Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Spencer Pharmaceutical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Spencer Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Spencer Pharmaceutical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Spencer Pharmaceutical.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in Spencer Pharmaceutical on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Spencer Pharmaceutical or generate 0.0% return on investment in Spencer Pharmaceutical over 90 days. Spencer Pharmaceutical Inc. develops drug platform technologies for the treatment of neurological deceases More
Spencer Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Spencer Pharmaceutical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Spencer Pharmaceutical upside and downside potential and time the market with a certain degree of confidence.
Spencer Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Spencer Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Spencer Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Spencer Pharmaceutical historical prices to predict the future Spencer Pharmaceutical's volatility.Spencer Pharmaceutical Backtested Returns
We have found three technical indicators for Spencer Pharmaceutical, which you can use to evaluate the volatility of the company. The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Spencer Pharmaceutical are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Spencer Pharmaceutical has perfect predictability. Overlapping area represents the amount of predictability between Spencer Pharmaceutical time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Spencer Pharmaceutical price movement. The serial correlation of 1.0 indicates that 100.0% of current Spencer Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Spencer Pharmaceutical reported net income of (943,196). This is 100.28% lower than that of the Healthcare sector and 101.35% lower than that of the Biotechnology industry. The net income for all United States stocks is 100.17% higher than that of the company.
Spencer Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Spencer Pharmaceutical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Spencer Pharmaceutical could also be used in its relative valuation, which is a method of valuing Spencer Pharmaceutical by comparing valuation metrics of similar companies.Spencer Pharmaceutical is currently under evaluation in net income category among its peers.
Spencer Fundamentals
| Return On Asset | -1.42 | ||||
| Current Valuation | 1.18 M | ||||
| Price To Book | 0.35 X | ||||
| Net Income | (943.2 K) | ||||
| Cash And Equivalents | 455.93 K | ||||
| Total Debt | 2.91 M | ||||
| Current Ratio | 0.28 X | ||||
| Book Value Per Share | (0) X | ||||
| Cash Flow From Operations | 642.43 K | ||||
| Beta | 55.84 | ||||
| Market Capitalization | 1.34 M | ||||
| Total Asset | 772.2 K | ||||
| Net Asset | 772.2 K |
About Spencer Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Spencer Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Spencer Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Spencer Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out For more detail on how to invest in Spencer Stock please use our How to Invest in Spencer Pharmaceutical guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is there potential for Biotechnology market expansion? Will Spencer introduce new products? Factors like these will boost the valuation of Spencer Pharmaceutical. If investors know Spencer will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Spencer Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Spencer Pharmaceutical is measured differently than its book value, which is the value of Spencer that is recorded on the company's balance sheet. Investors also form their own opinion of Spencer Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Spencer Pharmaceutical's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Spencer Pharmaceutical's market value can be influenced by many factors that don't directly affect Spencer Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spencer Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Spencer Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Spencer Pharmaceutical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.